{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:20:09Z","timestamp":1793845209102,"version":"4.6.1"},"reference-count":89,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Breast cancer (BC) has superseded lung cancer as the most prevalent malignant neoplasm globally, posing a significant threat to human health. Currently, mammography and ultrasonography serve as the primary modalities for early breast cancer screening. However, X-ray examination exhibits low sensitivity, while ultrasonography has a high false positive rate, which can readily lead to overdiagnosis and overtreatment. Peripheral blood mononuclear cells (PBMCs), which are specialized immune cells generated by hematopoietic stem cells (HSCs), actively monitor any indications of infection, foreign invaders, and abnormal or aberrant cells associated with diseases. Given that PBMCs respond to diverse pathophysiological stimuli in the form of immune responses\/immune phenotypic changes, the study of the molecular constituents of PBMCs can facilitate a better understanding of the immune process. Simultaneously, as PBMCs can be isolated from peripheral blood and detected in liquid form, they offer a non-invasive and suitable source of biomarkers. The analysis of PBMCs in cancer patients can be utilized for the early screening and diagnosis of breast cancer, as well as for evaluating therapeutic efficacy and prognosis. This article reviews the clinical application of PBMCs in breast cancer, highlighting its advantages and limitations.<\/jats:p>","DOI":"10.3389\/fcell.2025.1721106","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T07:13:44Z","timestamp":1765350824000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical application of PBMCs in breast cancer: detection, treatment evaluation and prognosis"],"prefix":"10.3389","volume":"13","author":[{"given":"Bo","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"825703","DOI":"10.3389\/fonc.2022.825703","article-title":"Cell senescence-related pathways are enriched in breast cancer patients with late toxicity after radiotherapy and low radiation-induced lymphocyte apoptosis","volume":"12","author":"Aguado-Flor","year":"2022","journal-title":"Front. Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e2200026","DOI":"10.1002\/pmic.202200026","article-title":"Human peripheral blood mononuclear cells: a review of recent proteomic applications","volume":"22","author":"Alexovi\u010d","year":"2022","journal-title":"Proteomics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"105698","DOI":"10.1016\/j.jbspin.2024.105698","article-title":"Regulation of SOCS3-STAT3 in urate-induced cytokine production in human myeloid cells","volume":"91","author":"Badii","year":"2024","journal-title":"Jt. Bone Spine"},{"key":"B4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/jir.2019.0106","article-title":"Evaluation of interleukin 25 and interleukin 25 receptor expression in peripheral blood mononuclear cells of breast cancer patients and normal subjects","volume":"40","author":"Barati","year":"2020","journal-title":"J. Interferon Cytokine Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"6291","DOI":"10.3390\/cancers13246291","article-title":"Genome-wide DNA methylation signatures predict the early asymptomatic doxorubicin-induced cardiotoxicity in breast cancer","volume":"13","author":"Bauer","year":"2021","journal-title":"Cancers"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/mc.23242","article-title":"Analysis of circulating breast cancer cell heterogeneity and interactions with peripheral blood mononuclear cells","volume":"59","author":"Brechbuhl","year":"2020","journal-title":"Mol. Carcinog."},{"key":"B7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/clinchem\/hvad191","article-title":"Breast cancer circulating tumor cells: current clinical applications and future prospects","volume":"70","author":"Cani","year":"2024","journal-title":"Clin. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"103674","DOI":"10.1016\/j.breast.2024.103674","article-title":"Breast cancer highlights from 2023: knowledge to guide practice and future research","volume":"74","author":"Cardoso","year":"2024","journal-title":"Breast"},{"key":"B9","doi-asserted-by":"publisher","first-page":"102138","DOI":"10.1016\/j.tranon.2024.102138","article-title":"Transient-resting culture after activation enhances the generation of CD8(+) stem cell-like memory T cells from peripheral blood mononuclear cells","volume":"50","author":"Chen","year":"2024","journal-title":"Transl. Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1200\/JCO.21.00944","article-title":"E2112: randomized phase III trial of endocrine therapy plus entinostat or placebo in hormone receptor-positive advanced breast cancer. A trial of the ECOG-ACRIN cancer research group","volume":"39","author":"Connolly","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"102624","DOI":"10.1016\/j.ctrv.2023.102624","article-title":"Estrogen deprivation effects of endocrine therapy in breast cancer patients: incidence, management and outcome","volume":"120","author":"Cucciniello","year":"2023","journal-title":"Cancer Treat. Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e2308174","DOI":"10.1002\/advs.202308174","article-title":"Landscape of the peripheral immune response induced by intraoperative radiotherapy combined with surgery in early breast cancer patients","volume":"2024","author":"Dai","year":"2024","journal-title":"Adv. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3390\/biomedicines12040809","article-title":"PBMCs as tool for identification of novel immunotherapy biomarkers in lung cancer","volume":"12","author":"De Rosa","year":"2024","journal-title":"Biomedicines"},{"key":"B14","doi-asserted-by":"publisher","first-page":"110591","DOI":"10.1016\/j.radonc.2024.110591","article-title":"Dose constraints in breast cancer radiotherapy. A critical review","volume":"202","author":"De Rose","year":"2024","journal-title":"Radiother. Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1139\/bcb-2020-0559","article-title":"Preventive cancer vaccination with P5 HER-2\/neo-derived peptide-pulsed peripheral blood mononuclear cells in a mouse model of breast cancer","volume":"99","author":"Dehghan-Manshadi","year":"2021","journal-title":"Biochem. Cell Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1080\/09553002.2022.2063432","article-title":"Overexpression of TIGAR and HO-1 in peripheral blood mononuclear cells (PBMCs) of breast cancer patients treated with radiotherapy","volume":"98","author":"Dianati-Nasab","year":"2022","journal-title":"Int. J. Radiat. Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/ijms22010371","article-title":"MMP1 and MMP11 expression in peripheral blood mononuclear cells upon their interaction with breast cancer cells and fibroblasts","volume":"22","author":"Eiro","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1307621","DOI":"10.3389\/fimmu.2023.1307621","article-title":"Immunogenicity and efficacy of an oral live-attenuated vaccine for bovine Johne's disease","volume":"14","author":"Eshraghisamani","year":"2023","journal-title":"Front. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e000450","DOI":"10.1136\/jitc-2019-000450","article-title":"PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations","volume":"8","author":"Fabian","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1038\/s41467-021-22024-3","article-title":"Epigenetic mechanisms in breast cancer therapy and resistance","volume":"12","author":"Garcia-Martinez","year":"2021","journal-title":"Nat. Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41416-023-02375-y","article-title":"Alterations in immune cell phenotype and cytotoxic capacity in HER2+ breast cancer patients receiving HER2-targeted neo-adjuvant therapy","volume":"129","author":"Gaynor","year":"2023","journal-title":"Br. J. Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1515\/cclm-2022-0003","article-title":"Delays during PBMC isolation have a moderate effect on yield, but severly compromise cell viability","volume":"60","author":"Golke","year":"2022","journal-title":"Clin. Chem. Lab. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e134569","DOI":"10.1172\/jci.insight.134569","article-title":"Immune cell repertoires in breast cancer patients after adjuvant chemotherapy","volume":"5","author":"Gustafson","year":"2020","journal-title":"JCI Insight"},{"key":"B24","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ccell.2020.03.009","article-title":"Overcoming endocrine resistance in breast cancer","volume":"37","author":"Hanker","year":"2020","journal-title":"Cancer Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.22038\/ijbms.2024.79378.17194","article-title":"Doxorubicin-loaded NK exosomes enable cytotoxicity against triple-negative breast cancer spheroids","volume":"27","author":"Hashemi","year":"2024","journal-title":"Iran. J. Basic Med. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1080\/17425247.2024.2412823","article-title":"Breast cancer epidemiology, diagnostic barriers, and contemporary trends in breast nanotheranostics and mechanisms of targeting","volume":"21","author":"Ibrahim","year":"2024","journal-title":"Expert Opin. Drug Deliv."},{"key":"B27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.18502\/ijaai.v21i1.8608","article-title":"Altered expression levels of MicroRNA-155 and SOCS-1 in peripheral blood mononuclear cells of newly diagnosed breast cancer patients","volume":"21","author":"Iranparast","year":"2022","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3322\/caac.21838","article-title":"Global cancer statistics: a healthy population relies on population health","volume":"74","author":"Jokhadze","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"B29","doi-asserted-by":"publisher","first-page":"101576","DOI":"10.1016\/j.tice.2021.101576","article-title":"Role of breast cancer-derived exosomes in metabolism of immune cells through PD1-GLUT1-HK2 metabolic axis","volume":"71","author":"Joudaki","year":"2021","journal-title":"Tissue Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10549-022-06601-8","article-title":"RT-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with breast cancer indicate poor prognosis","volume":"193","author":"Kim","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"key":"B31","doi-asserted-by":"publisher","first-page":"107867","DOI":"10.1016\/j.compbiolchem.2023.107867","article-title":"Peripheral blood mononuclear cell derived biomarker detection using eXplainable artificial intelligence (XAI) provides better diagnosis of breast cancer","volume":"104","author":"Kumar","year":"2023","journal-title":"Comput. Biol. Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2147\/CMAR.S227628","article-title":"Associations between miRNAs and two different cancers: breast and colon","volume":"12","author":"Kundaktepe","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3390\/cells11101639","article-title":"Peripheral blood mononuclear cell populations correlate with outcome in patients with metastatic breast cancer","volume":"11","author":"Larsson","year":"2022","journal-title":"Cells"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1200\/JCO.23.00455","article-title":"Endocrine therapy for primary and secondary prevention after diagnosis of high-risk breast lesions or preinvasive breast cancer","volume":"41","author":"Laws","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1007\/s00262-022-03157-w","article-title":"Targeting transforming growth factor-\u03b22 by antisense oligodeoxynucleotide accelerates T cell-mediated tumor rejection in a humanized mouse model of triple-negative breast cancer","volume":"71","author":"Lee","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.3390\/biomedicines12091970","article-title":"Changes in mitochondrial function and cell death patterns in peripheral blood mononuclear cells during trastuzumab treatment following doxorubicin chemotherapy","volume":"12","author":"Leemasawat","year":"2024","journal-title":"Biomedicines"},{"key":"B37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13058-024-01848-z","article-title":"Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancer","volume":"26","author":"Leon-Ferre","year":"2024","journal-title":"Breast Cancer Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.7150\/thno.80294","article-title":"Proteomes from AMPK-inhibited peripheral blood mononuclear cells suppress the progression of breast cancer and bone metastasis","volume":"13","author":"Li","year":"2023","journal-title":"Theranostics"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.2147\/OTT.S326178","article-title":"A novel CD73 inhibitor SHR170008 suppresses adenosine in tumor and enhances anti-tumor activity with PD-1 blockade in a mouse model of breast cancer","volume":"14","author":"Liu","year":"2021","journal-title":"Onco Targets Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13058-023-01665-w","article-title":"Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment","volume":"25","author":"Liu","year":"2023","journal-title":"Res. Sq."},{"key":"B41","doi-asserted-by":"publisher","first-page":"100085","DOI":"10.1016\/j.xhgg.2022.100085","article-title":"Prediction of breast cancer risk based on flow variant analysis of circulating peripheral blood mononuclear cells","volume":"3","author":"Loke","year":"2022","journal-title":"HGG Adv."},{"key":"B42","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00262-022-03278-2","article-title":"Single-cell and spatial transcriptome analyses revealed cell heterogeneity and immune environment alternations in metastatic axillary lymph nodes in breast cancer","volume":"72","author":"Mao","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S1470-2045(21)00539-8","article-title":"European society for radiotherapy and oncology advisory committee in radiation oncology practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer","volume":"23","author":"Meattini","year":"2022","journal-title":"Lancet Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2147\/BCTT.S337075","article-title":"Detection of minimal residual disease in the peripheral blood of breast cancer patients, with a multi marker (MGB-1, MGB-2, CK-19 and NY-BR-1) assay","volume":"13","author":"Meijer","year":"2021","journal-title":"Breast Cancer (Dove Med. Press)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"100303","DOI":"10.1016\/j.labinv.2023.100303","article-title":"The prognostic value of CD39 as a marker of tumor-specific T cells in triple-negative breast cancer in Asian women","volume":"104","author":"Meng","year":"2024","journal-title":"Lab. Invest"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3389\/fonc.2020.01101","article-title":"Identification and validation of stage-associated PBMC biomarkers in breast cancer using MS-based proteomics","volume":"10","author":"Moradpoor","year":"2020","journal-title":"Front. Oncol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1001\/jamaoncol.2023.7322","article-title":"PARP inhibitors for breast cancer treatment: a review","volume":"10","author":"Morganti","year":"2024","journal-title":"JAMA Oncol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1080\/13813455.2020.1752257","article-title":"PBMCs: a new source of diagnostic and prognostic biomarkers","volume":"128","author":"Mosallaei","year":"2022","journal-title":"Arch. Physiol. Biochem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"12992","DOI":"10.3390\/ijms232112992","article-title":"Capability of human dendritic cells pulsed with autologous induced pluripotent stem cell lysate to induce cytotoxic T lymphocytes against HLA-A33-matched cancer cells","volume":"23","author":"Nakazawa","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"Cd013658","DOI":"10.1002\/14651858.CD013658.pub2","article-title":"Oncoplastic breast-conserving surgery for women with primary breast cancer","volume":"10","author":"Nanda","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3390\/cancers13051119","article-title":"The mechanical fingerprint of circulating tumor cells (CTCs) in breast cancer patients","volume":"13","author":"Nel","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"22220","DOI":"10.1038\/s41598-021-01683-8","article-title":"Alterations of the 70 kDa heat shock protein (HSP70) and sequestosome-1 (p62) in women with breast cancer","volume":"11","author":"Orfanelli","year":"2021","journal-title":"Sci. Rep."},{"key":"B53","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejca.2021.11.025","article-title":"Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trial","volume":"162","author":"Peuker","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.5301\/JBM.2012.9235","article-title":"Impact of preanalytical handling and timing for peripheral blood mononuclear cells isolation and RNA studies: the experience of the interinstitutional multidisciplinary BioBank (BioBIM)","volume":"27","author":"Palmirotta","year":"2012","journal-title":"Int. J. Biol. Markers"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3390\/cancers14041053","article-title":"TLR4 and pSTAT3 expression on circulating tumor cells (CTCs) and immune cells in the peripheral blood of breast cancer patients: prognostic implications","volume":"14","author":"Papadaki","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B56","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41571-020-0388-9","article-title":"Personalized early detection and prevention of breast cancer: ENVISION consensus statement","volume":"17","author":"Pashayan","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"11057","DOI":"10.1038\/s41598-024-61378-8","article-title":"Detection of circulating tumor cells by means of machine learning using Smart-Seq2 sequencing","volume":"14","author":"Pastuszak","year":"2024","journal-title":"Sci. Rep."},{"key":"B58","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s12885-020-06835-z","article-title":"GRP78 expression in peripheral blood mononuclear cells is a new predictive marker for the benefit of taxanes in breast cancer neoadjuvant treatment","volume":"20","author":"Raiter","year":"2020","journal-title":"BMC Cancer"},{"key":"B59","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.trecan.2024.02.008","article-title":"The anti-cancer immune response in breast cancer: current and emerging biomarkers and treatments","volume":"10","author":"Rayson","year":"2024","journal-title":"Trends Cancer"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1007\/s11033-024-10007-8","article-title":"Triple-negative breast cancer-derived exosomes change the immunological features of human monocyte-derived dendritic cells and influence T-cell responses","volume":"51","author":"Safaei","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"B61","doi-asserted-by":"publisher","first-page":"104010","DOI":"10.1016\/j.ebiom.2022.104010","article-title":"Immune effects of CDK4\/6 inhibitors in patients with HR(+)\/HER2(-) metastatic breast cancer: relief from immunosuppression is associated with clinical response","volume":"79","author":"Scirocchi","year":"2022","journal-title":"EBioMedicine"},{"key":"B62","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1001\/jamasurg.2023.6382","article-title":"Benign breast disease and breast cancer risk in the percutaneous biopsy Era","volume":"159","author":"Sherman","year":"2024","journal-title":"JAMA Surg."},{"key":"B63","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13072-020-00372-6","article-title":"Comparison of methylation capture sequencing and infinium MethylationEPIC array in peripheral blood mononuclear cells","volume":"13","author":"Shu","year":"2020","journal-title":"Epigenetics Chromatin"},{"key":"B64","doi-asserted-by":"publisher","first-page":"101258","DOI":"10.1016\/j.mam.2024.101258","article-title":"Circulating tumor cells as liquid biopsy markers in cancer patients","volume":"96","author":"Smit","year":"2024","journal-title":"Mol. Asp. Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13045-024-01577-y","article-title":"Harnessing extracellular vesicles using liquid biopsy for cancer diagnosis and monitoring: highlights from AACR annual meeting 2024","volume":"17","author":"Su","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.mayocp.2023.12.006","article-title":"Breast cancer screening recommendations for transgender patients: a review","volume":"99","author":"Suarez","year":"2024","journal-title":"Mayo Clin. Proc."},{"key":"B67","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00262-024-03627-3","article-title":"Stimulating T cell responses against patient-derived breast cancer cells with neoantigen peptide-loaded peripheral blood mononuclear cells","volume":"73","author":"Sueangoen","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"B68","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/cac2.12190","article-title":"Nuclear aurora kinase A triggers programmed death-ligand 1-mediated immune suppression by activating MYC transcription in triple-negative breast cancer","volume":"41","author":"Sun","year":"2021","journal-title":"Cancer Commun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","article-title":"Targeting HER2-positive breast cancer: advances and future directions","volume":"22","author":"Swain","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"B70","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/cge.13900","article-title":"Molecular intrinsic versus clinical subtyping in breast cancer: a comprehensive review","volume":"99","author":"Szymiczek","year":"2021","journal-title":"Clin. Genet."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e000883","DOI":"10.1136\/jitc-2020-000883","article-title":"An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors","volume":"8","author":"Taylor","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1038\/s41588-024-02019-8","article-title":"Single-cell RNA sequencing of peripheral blood links cell-type-specific regulation of splicing to autoimmune and inflammatory diseases","volume":"56","author":"Tian","year":"2024","journal-title":"Nat. Genet."},{"key":"B73","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13045-021-01132-z","article-title":"Phase 1 study of M2698, a p70S6K\/AKT dual inhibitor, in patients with advanced cancer","volume":"14","author":"Tsimberidou","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13073-021-00874-2","article-title":"Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer","volume":"13","author":"Tzeng","year":"2021","journal-title":"Genome Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.ijrobp.2024.01.001","article-title":"Immunotherapy and radiation therapy sequencing in breast cancer: a systematic review","volume":"118","author":"Verma","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"B76","doi-asserted-by":"publisher","first-page":"107404","DOI":"10.1016\/j.intimp.2021.107404","article-title":"Baseline effector cells predict response and NKT cells predict pulmonary toxicity in advanced breast cancer patients treated with everolimus and exemestane","volume":"93","author":"Willemsen","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"4724","DOI":"10.1038\/s41467-023-40389-5","article-title":"A multiplex blood-based assay targeting DNA methylation in PBMCs enables early detection of breast cancer","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"B78","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41590-024-02059-6","article-title":"Integrating single-cell RNA and T cell\/B cell receptor sequencing with mass cytometry reveals dynamic trajectories of human peripheral immune cells from birth to old age","volume":"26","author":"Wang","year":"2025","journal-title":"Nat. Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"100752","DOI":"10.1016\/j.omto.2023.100752","article-title":"The role and application of vesicles in triple-negative breast cancer: opportunities and challenges","volume":"31","author":"Wei","year":"2023","journal-title":"Mol. Ther. Oncolytics"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1007\/s11764-023-01380-7","article-title":"Body composition and chemotherapy toxicity among women treated for breast cancer: a systematic review","volume":"18","author":"Wopat","year":"2024","journal-title":"J. Cancer Surviv."},{"key":"B81","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s40364-024-00643-4","article-title":"Single-cell sequencing to multi-omics: technologies and applications","volume":"12","author":"Wu","year":"2024","journal-title":"Biomark. Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1465586","DOI":"10.3389\/fphar.2024.1465586","article-title":"Analysis of chromatin accessibility in peripheral blood mononuclear cells from patients with early-stage breast cancer","volume":"15","author":"Xia","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1158\/0008-5472.CAN-22-3402","article-title":"DNA methylation-based testing in peripheral blood mononuclear cells enables accurate and early detection of colorectal cancer","volume":"83","author":"Xie","year":"2023","journal-title":"Cancer Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"113514","DOI":"10.1016\/j.jim.2023.113514","article-title":"Impact of delayed PBMC processing on functional and genomic assays","volume":"519","author":"Yi","year":"2023","journal-title":"J. Immunol. Methods"},{"key":"B85","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/14622416.2024.2404819","article-title":"Effects of immunorelated gene polymorphisms on trastuzumab targeting breast cancer cell in vitro","volume":"25","author":"Yu","year":"2024","journal-title":"Pharmacogenomics"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3906\/sag-2008-292","article-title":"The association between mRNA expression of resistin, TNF- \u03b1, IL-6, IL-8, and ER-\u03b1 in peripheral blood mononuclear cells and breast cancer","volume":"51","author":"Zare Moayedi","year":"2021","journal-title":"Turk J. Med. Sci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.3390\/cells12162094","article-title":"Skin-grafting and dendritic cell \u201cboosted\u201d humanized mouse models allow the pre-clinical evaluation of therapeutic cancer vaccines","volume":"12","author":"Zeng","year":"2023","journal-title":"Cells"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1186\/s12967-024-05842-z","article-title":"DNA methylation analysis of peripheral blood mononuclear cells in diagnosing breast cancer from benign breast lesions","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Transl. Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s11912-023-01393-6","article-title":"Advances in endocrine therapy for hormone receptor-positive advanced breast cancer","volume":"25","author":"Ziyeh","year":"2023","journal-title":"Curr. Oncol. Rep."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1721106\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T07:13:45Z","timestamp":1765350825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2025.1721106\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":89,"alternative-id":["10.3389\/fcell.2025.1721106"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2025.1721106","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"article-number":"1721106"}}